Impulsivity is both a risk factor for and a consequence of alcohol use disorder (AUD), for which mindfulness-based approaches have been proven to be effective. However, the specific relationship be...
Background and Aims: Although many people who use cannabis report mood-enhancing effects, affective responses are thought to vary within and between individuals. This study examined the bidirectional associations between momentary affect and cannabis use and the potential moderating role of emotion regulation in this. Design: Intensive longitudinal observational study using Experience Sampling Method (ESM)Setting: DenmarkParticipants: Adults in Denmark who use cannabis near daily (N = 113; Mage = 31.57 years; 60.2% male).Method and Measurements: Participants completed a baseline survey (substance use and emotion regulation difficulties) and 21 days of experience sampling (three assessments daily; affect and use). We used multilevel models to assess: 1) the associations between positive affect (PA) and negative affect (NA) and subsequent cannabis use, 2) whether cannabis use predicted changes in affect shortly after use (at the same assessment), and 3) whether cannabis use predicted changes in affect at a later moment (at the next assessment). Next, we assessed whether emotion regulation difficulties moderated associations tested in Models 1 and 2. Findings: Higher PA predicted a greater likelihood of cannabis use before the next assessment, and cannabis use predicted increased PA at the same assessment, but not at the next assessment. NA was not related to use or vice versa at group level. Emotion regulation difficulties moderated the association between PA and subsequent cannabis use, such that individuals with greater difficulties had a weaker positive association between positive affect and subsequent cannabis use. Furthermore, emotion regulation difficulties moderated short-term effects of cannabis use on NA, with individuals with higher emotion regulation difficulties showing lower NA shortly after use compared to non-use moments. Conclusions: Within individuals who use cannabis near daily, relatively higher momentary PA, but not NA, preceded and followed cannabis use. Cannabis use was associated with higher PA at the same assessment but did not predict PA hours later. Individuals with greater emotion regulation difficulties may experience short term reductions in NA after use.
Background and Aims: Alcohol is the top substance used by US emerging adults under legal drinking age (underage emerging adults; U-EA; ages 18-19). U-EA are unlikely to seek or receive indicated alcohol interventions. It is imperative to find brief, effective interventions to reduce U-EA drinking. Developmental neuroscience reflects that peers hold higher neural salience during adolescence, as evidenced by differential neural response with real and/or simulated peers, even when those peers were not friends, and particularly in the context of alcohol. Peers also activate positive (prosocial) neural and behavioral responses among adolescents. The role of positive, prosocial peer feedback is consequential given that the most widely-used U-EA platforms for adolescent addiction intervention are group-based interventions. We propose functional magnetic resonance imaging (fMRI) hyperscanning (tandem dyadic scanning) to evaluate U-EA brain response in the underexamined, but widely-utilized, group motivational interviewing (MI). We will examine associations between youth brain synchrony generated in an fMRI hyperscanning task and alcohol use reductions at 12 month follow-up. We hypothesize that greater neural alignment in the social cognition network during positive, prosocial peer interactions (peer-directed change talk) will be associated with greater post-intervention behavior change (lower number of past month drinking days) at 12 months. Design: Within-subjects Setting: UConn Health and UT-Dallas Participants: This study will enroll n=248 U-EA (ages 18-19) with ≥1 past month binge drinking event (4/3 standard drinks per occasion for males/females) via community and campus recruitment Intervention and comparator: Group MI (no comparator; within-subjects) Measurements: This protocol will utilize synchronized fMRI (hyperscanning) to examine positive, prosocial peer-directed health promotive language (peer-directed change talk) directly generated during and extracted from the group MI session. Primary outcomes include fMRI-based hyperscanning metrics (BOLD synchrony in social cognition networks) and behavioral measures (past month alcohol use days measured viaTimeline Followback; TLFB) at 12 months. Secondary outcomes will evaluate the same relationship at 3- and 6-months. Comment: This translational study is crucial for making meaningful gains in adolescent addiction intervention. We could find no peer-reviewed studies examining fMRI hyperscanning in an adolescent addiction intervention context. And, fMRI hyperscanning is at the forefront of interactive, dyadic youth research in socially-relevant and ecologically valid settings. In addition, due to the limited empirical evaluations of group interventions, including group MI, the use of fMRI hyperscanning is timely and offers a unique examination with high clinical impact for young people struggling with addiction.
Rationale: People who use cannabis often report using it to improve sleep and/or manage mental health symptoms. Cannabis products differ in their typical cannabinoid composition, particularly in their relative THC and CBD content, which may impact health outcomes differently. Objectives: This naturalistic study investigated associations between cannabis use and related problems, sleep quality, and symptoms of anxiety/depression among people who use cannabis near daily and examined the role of cannabis product types. Methods: Danish adults who reported using cannabis on 26.15 ± 6.23 days/month completed an online survey (197 participants; 64.5% men, Mage 30.7 ± 10.63 years) measuring past-month use of cannabis (including product types), severity of cannabis use and related problems (CUDIT-R), sleep quality (B-PSQI), and symptoms of anxiety/depression (PHQ-4). OLS regression models were used to examine associations and interaction terms were used to test moderation. Results: Severity of cannabis use and related problems, as indexed by CUDIT-R, was associated with poorer sleep quality and higher levels of anxiety/depression symptoms, which was not moderated by cannabis product type. Product type explained additional variance in sleep quality, but not in anxiety/depression symptoms. Individuals who reported using hash only and multiple THC-dominant product types exhibited poorer sleep quality compared with those who used flower only, independent of severity of cannabis use and related problems. Conclusions: Severity of cannabis use and related problems was linked with sleep and mental health problems, and product type did not alter the strength of these associations. Use of hash or multiple THC-dominant product was associated with more sleep problems than use of flower, adding to the literature showing that products with greater THC concentration are more harmful. Longitudinal studies are needed to establish causal relationships.
Background and aims: Although many people who use cannabis report mood‐enhancing effects, affective responses are thought to vary within and between individuals. This study examined the bidirectional associations between momentary affect and cannabis use and the potential moderating role of emotion regulation in this. Design: Intensive longitudinal observational study using experience sampling method (ESM). Setting: Denmark. Participants: Adults in Denmark who use cannabis near daily ( n = 113; Age: mean = 31.57 years, median = 29 years, standard deviation = 10.28, inter‐quartile range = 23–36; 60.2% male). Method and measurements: Participants completed a baseline survey (substance use and emotion regulation difficulties) and 21 days of experience sampling (three assessments daily; affect and use). We used multilevel models to assess: (1) the associations between positive affect (PA) and negative affect (NA) and subsequent cannabis use, (2) whether cannabis use predicted changes in affect shortly after use (at the same assessment) and (3) whether cannabis use predicted changes in affect at a later moment (at the next assessment). Next, we assessed whether emotion regulation difficulties moderated associations tested in models 1 and 2. Findings: Higher PA predicted a greater likelihood of cannabis use before the next assessment [odds ratio (OR) = 1.05, 95% confidence interval (CI) = 1.01–1.09], and cannabis use predicted increased PA at the same assessment (b = 0.59, 95% CI = 0.27–0.92), but not at the next assessment. NA was not related to use or vice versa at group level. Emotion regulation difficulties did not statistically significantly moderate the associations between PA or NA and subsequent cannabis use; however, emotion regulation difficulties moderated short‐term effects of cannabis use on NA (b = −0.014, 95% CI = −0.027 to −0.002), with individuals with higher emotion regulation difficulties showing lower NA shortly after use compared with non‐use moments. Conclusions: Within individuals who use cannabis near daily, relatively higher momentary positive affect, but not negative affect, appears to precede and follow cannabis use. Cannabis use appears to be associated with higher positive effect at the time of assessment but does not predict positive affect hours later. Individuals with greater emotion regulation difficulties may experience short‐term reductions in negative effect after cannabis use.